Bioxytran (BIXT) EBITDA Margin (QoQ) (2010 - 2018)
Bioxytran (BIXT) EBITDA Margin (QoQ) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 368.00 |
| Mar 31, 2018 | 26,342.00 |
| Dec 31, 2017 | -31,384.00 |
| Sep 30, 2017 | 70,021.00 |
| Jun 30, 2017 | 18,752.00 |
| Mar 31, 2017 | -107,812.00 |
| Dec 31, 2016 | 44,544.00 |
| Sep 30, 2016 | 4,808.00 |
| Jun 30, 2016 | 117,951.00 |
| Mar 31, 2016 | -144,270.00 |
| Dec 31, 2015 | 3,087.00 |
| Sep 30, 2015 | 319,691.00 |
| Jun 30, 2015 | -316,278.00 |
| Mar 31, 2015 | -151,612.00 |
| Dec 31, 2014 | 414,181.00 |
| Sep 30, 2014 | -253,683.00 |
| Jun 30, 2014 | -17,996.00 |
| Mar 31, 2014 | 9,412.00 |
| Dec 31, 2013 | 43,128.00 |
| Sep 30, 2013 | 14,480.00 |